RevitalVision

RevitalVision Overview

RevitalVision is a SaaS-based digital health startup operating in the rapidly growing, $52 billion field of vision improvement in the ophthalmic marketplace. The company’s noninvasive technology enhances eyesight neurologically, offering an innovative solution to the 500 million people whose needs are unmet by existing vision treatments. RevitalVision’s thousands of clinical trial participants and commercial customers have reported and exhibited significant improvement in their vision performance by 2.5 lines on the visual acuity eye chart along with a 100% increase in contrast sensitivity on average for all product categories. RevitalVision is FDA-cleared for children older than 9 and adults with amblyopia (lazy eye), a leading cause of vision impairment that affects 3% to 5% of the world population. Using brain science and proprietary algorithm-based technology, RevitalVision is clinically validated for use for multiple eye diseases and vision impairments and has been approved for two new unique reimbursement codes by the American Medical Association for the treatment of amblyopia. RevitalVision provides eye care specialists with a simple, easy-to-use tool to improve patients’ vision beyond optical correction and other current eye treatments, as well as an additional revenue channel. The company also offers eye surgery clinics a valuable tool for reducing unpaid post-surgery visits by cataract and refractive patients who find it difficult to neuro-adapt or who suffer from reduced contrast sensitivity, poor night vision, or side effects such as halo and glare.

Cumulative Funding Raised Over Time ($)

Latest News

Apr 15, 2024 · en.globes.co.il

growth-positive

RevitalVision announces success in new trial

RevitalVision, a company that develops products to treat eye conditions by retraining the brain, has announced successful trials of a product for improving vision through visual stimulation. The product was tested for the treatment of nystagmus and keratoconus, conditions that affect eye movement and shape respectively. The companys products are already approved for the treatment of lazy eye syndrome. RevitalVision was founded in 2019 and has raised $4 million, partly through crowdfunding. The success of the new studies will assist the company in its marketing activity in the professional community.

InvestmentCustomers

Oct 11, 2021 · www.geektime.co.il

growth-positive

רגע לפני הפריצה לארה"ב: סבב גיוס שני לסטארטאפ ישראלי שפיתח טכנולוגיה לשיפור הראייה

Israeli startup RevitalVision, which has developed technology to improve vision, has raised over 3.2 million shekels in its second funding round. The companys technology, which is clinically proven, improves image processing in the brain rather than treating the eye. The company has over 340 investors and has recently received a treatment code in the US, a necessary step for insurance coverage in the country. The company has treated over 10,000 customers with its technology and is the only product with FDA efficiency approval for improving vision in lazy eye in adults.

InvestmentExpand

Jul 18, 2021 · www.globes.co.il

growth-positive

אישור FDA וקוד שיפוי ביטוח לחברת רויטל ויז'ן המטפלת בעין עצלה

Israeli company RevitalVision has received FDA approval and a specific reimbursement code in the US for its vision training software developed for the treatment of lazy eye in adults and children over the age of 9. The code will be effective from January 2022 and will allow doctors using the companys technology to collect payment for treatment using the product. The company recently raised $1 million through the PeopleBiz crowdfunding platform and is in the process of raising an additional $4 million.

InvestmentExpand

Mar 21, 2021 · www.calcalistech.com

growth-positive

Israel's RevitalVision expands its vision technology to U.S and Europe

RevitalVision, an Israeli vision training company, is preparing to launch its technology in the American and European markets. The companys technology stimulates the brains visual cortex to improve vision without invasive surgery. It is FDA-approved and specifically targets amblyopic adults, who make up 3% of the population. RevitalVision has applied for a unique CPT code from the American Medical Association to enter the American healthcare system and receive reimbursement from insurance carriers. The company has already helped thousands of people achieve significant improvements in vision and quality of life. The technology has been successful in enabling individuals to pass vision tests and gain drivers licenses and admission to IDF pilot courses.

Customers

Oct 1, 2011 · www.healio.com

growth-positive

Home-based software offers physical therapy for the eyes

RevitalVision LLC, a company based in Lawrence, Kansas, has developed a computer-based vision therapy program that can be used by patients at home after undergoing LASIK and cataract surgery. The program, which is customized to the patients pace and visual ability, is monitored by a personal RevitalVision specialist. The length and duration of the program vary by patient and specific need. The program has shown to improve visual outcomes and patient satisfaction, with patients showing an objective improvement in Snellen acuity of 1.5 to 2.0 lines.

Customers

Funding

Team Members

5

Employees: 11-50

Web & Social Links

Locations

HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel

Photos & Videos

1 item(s)

RevitalVision Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info